HEPALINK (09989) announced its interim results for 2025, with revenue of approximately RMB 2.791 billion, down 1.3% year-on-year. Net profit attributable to shareholders of the parent company reached approximately RMB 422 million, representing a 36.4% decrease compared to the same period last year. Earnings per share stood at RMB 0.29. According to the announcement, the year-on-year decline in net profit was primarily due to significant one-time investment gains that positively impacted the same period in 2024, creating a substantial comparative effect on current period profit changes.